These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26260214)

  • 1. Variation in PARK10 is not associated with risk and age at onset of Parkinson's disease in large clinical cohorts.
    Simón-Sánchez J; Heutink P; Gasser T;
    Neurobiol Aging; 2015 Oct; 36(10):2907.e13-7. PubMed ID: 26260214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.
    Pan HX; Zhao YW; Mei JP; Fang ZH; Wang Y; Zhou X; Zhou YJ; Zhang R; Zhang KL; Jiang L; Zeng Q; He Y; Wang Z; Liu ZH; Xu Q; Sun QY; Yang Y; Hu YC; Chen YS; Du J; Lei LF; Zhang HN; Wang CY; Yan XX; Shen L; Jiang H; Tan JQ; Li JC; Tang BS; Guo JF
    Transl Neurodegener; 2020 Aug; 9(1):31. PubMed ID: 32746945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of rare damaging variants in hereditary atypical parkinsonism genes is increased in patients with Parkinson's disease.
    Kim YJ; Lee J; Kim NY; Hong S; Cho YS; Yoon J
    Neurobiol Aging; 2021 Apr; 100():118.e5-118.e13. PubMed ID: 33423827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.
    Mata IF; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Van Deerlin VM; Ritz B; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson-Hiller AL; Espay AJ; Revilla FJ; Devoto J; Yearout D; Hu SC; Cholerton BA; Montine TJ; Edwards KL; Zabetian CP
    Neurobiol Aging; 2017 Aug; 56():211.e1-211.e7. PubMed ID: 28526295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of early-onset Parkinson's disease in Finland: exome sequencing and genome-wide association study.
    Siitonen A; Nalls MA; Hernández D; Gibbs JR; Ding J; Ylikotila P; Edsall C; Singleton A; Majamaa K
    Neurobiol Aging; 2017 May; 53():195.e7-195.e10. PubMed ID: 28256260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association mapping of the PARK10 region for Parkinson's disease susceptibility genes.
    Wan JY; Edwards KL; Hutter CM; Mata IF; Samii A; Roberts JW; Agarwal P; Checkoway H; Farin FM; Yearout D; Zabetian CP
    Parkinsonism Relat Disord; 2014 Jan; 20(1):93-8. PubMed ID: 24156912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
    Lubbe SJ; Escott-Price V; Brice A; Gasser T; Pittman AM; Bras J; Hardy J; Heutink P; Wood NM; Singleton AB; Grosset DG; Carroll CB; Law MH; Demenais F; Iles MM; ; Bishop DT; Newton-Bishop J; Williams NM; Morris HR;
    Neurobiol Aging; 2016 Dec; 48():222.e1-222.e7. PubMed ID: 27640074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease.
    Nuytemans K; Bademci G; Inchausti V; Dressen A; Kinnamon DD; Mehta A; Wang L; Züchner S; Beecham GW; Martin ER; Scott WK; Vance JM
    Neurology; 2013 Mar; 80(11):982-9. PubMed ID: 23408866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease.
    Berge-Seidl V; Pihlstrøm L; Wszolek ZK; Ross OA; Toft M
    Neurobiol Aging; 2019 Feb; 74():236.e1-236.e5. PubMed ID: 30340792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease.
    Clark J; Reddy S; Zheng K; Betensky RA; Simon DK
    BMC Med Genet; 2011 May; 12():69. PubMed ID: 21595954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No relationship between SRY variants and risk of Parkinson's disease in Chinese population.
    Pan H; Wang Y; Zhao Y; Jiang L; Zeng Q; He Y; Fang Z; Wang Z; Xu Q; Sun Q; Tan J; Yan X; Li J; Tang B; Guo J
    Neurobiol Aging; 2021 Apr; 100():119.e3-119.e6. PubMed ID: 33041088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication assessment of NUS1 variants in Parkinson's disease.
    Bustos BI; Bandres-Ciga S; Gibbs JR; Krainc D; Mencacci NE; Gan-Or Z; Lubbe SJ;
    Neurobiol Aging; 2021 May; 101():300.e1-300.e3. PubMed ID: 33309333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.
    Hamza TH; Zabetian CP; Tenesa A; Laederach A; Montimurro J; Yearout D; Kay DM; Doheny KF; Paschall J; Pugh E; Kusel VI; Collura R; Roberts J; Griffith A; Samii A; Scott WK; Nutt J; Factor SA; Payami H
    Nat Genet; 2010 Sep; 42(9):781-5. PubMed ID: 20711177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility and implications of exome sequencing in early-onset Parkinson's disease.
    Trinh J; Lohmann K; Baumann H; Balck A; Borsche M; Brüggemann N; Dure L; Dean M; Volkmann J; Tunc S; Prasuhn J; Pawlack H; Imhoff S; Lill CM; Kasten M; Bauer P; Rolfs A; ; Klein C
    Mov Disord; 2019 Jan; 34(1):133-137. PubMed ID: 30537300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIC3 variants are not associated with Parkinson's disease in large European, Latin American, or East Asian cohorts.
    Brolin K; Bandres-Ciga S; Leonard H; Makarious MB; Blauwendraat C; Mata IF; Foo JN; Pihlstrøm L; Swanberg M; Gan-Or Z; Tan MM;
    Neurobiol Aging; 2022 Jan; 109():264-268. PubMed ID: 34538707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.
    Mok KY; Sheerin U; Simón-Sánchez J; Salaka A; Chester L; Escott-Price V; Mantripragada K; Doherty KM; Noyce AJ; Mencacci NE; Lubbe SJ; ; Williams-Gray CH; Barker RA; van Dijk KD; Berendse HW; Heutink P; Corvol JC; Cormier F; Lesage S; Brice A; Brockmann K; Schulte C; Gasser T; Foltynie T; Limousin P; Morrison KE; Clarke CE; Sawcer S; Warner TT; Lees AJ; Morris HR; Nalls MA; Singleton AB; Hardy J; Abramov AY; Plagnol V; Williams NM; Wood NW
    Lancet Neurol; 2016 May; 15(6):585-96. PubMed ID: 27017469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease.
    Beecham GW; Dickson DW; Scott WK; Martin ER; Schellenberg G; Nuytemans K; Larson EB; Buxbaum JD; Trojanowski JQ; Van Deerlin VM; Hurtig HI; Mash DC; Beach TG; Troncoso JC; Pletnikova O; Frosch MP; Ghetti B; Foroud TM; Honig LS; Marder K; Vonsattel JP; Goldman SM; Vinters HV; Ross OA; Wszolek ZK; Wang L; Dykxhoorn DM; Pericak-Vance MA; Montine TJ; Leverenz JB; Dawson TM; Vance JM
    Neurology; 2015 Mar; 84(10):972-80. PubMed ID: 25663231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing the role of rare coding variants in known Parkinson's disease risk loci.
    Jansen IE; Gibbs JR; Nalls MA; Price TR; Lubbe S; van Rooij J; Uitterlinden AG; Kraaij R; Williams NM; Brice A; Hardy J; Wood NW; Morris HR; Gasser T; Singleton AB; Heutink P; Sharma M;
    Neurobiol Aging; 2017 Nov; 59():220.e11-220.e18. PubMed ID: 28867149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
    von Otter M; Bergström P; Quattrone A; De Marco EV; Annesi G; Söderkvist P; Wettinger SB; Drozdzik M; Bialecka M; Nissbrandt H; Klein C; Nilsson M; Hammarsten O; Nilsson S; Zetterberg H
    BMC Med Genet; 2014 Dec; 15():131. PubMed ID: 25496089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.